Are you Dr. Frangogiannis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 61 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Baylor Plz # Bcm620
Baylor College Of Medicine
Houston, TX 77030Phone+1 713-798-3391- Is this information wrong?
Summary
- Dr. Nikolaos Frangogiannis, MD is a cardiologist in Houston, Texas. He is currently licensed to practice medicine in Michigan.
Education & Training
- Baylor College of MedicineFellowship, Cardiovascular Disease, 1996 - 1999
- Baylor College of MedicineResidency, Internal Medicine, 1992 - 1996
- University of AthensClass of 1990
Certifications & Licensure
- MI State Medical License 1999 - 2021
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarct...Nikolaos G Frangogiannis> ;Circulation. 2024 Mar 19
- TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities.Frangogiannis, N.> ;Expert Opinion on Therapeutic Targets. 2024 Feb 19
- 1 citationsProtective effects of macrophage-specific integrin α5 in myocardial infarction are associated with accentuated angiogenesis.Li, R., Chen, B., Kubota, A., Hanna, A., Humeres, C., Hernandez, S., Liu, Y., Ma, R., Tuleta, I., Huang, S., Venugopal, H., Zhu, F., Su, K., Li, J., Zhang, J., Zheng, ...> ;Nature Communications. 2023 Nov 20
- Join now to see all
Press Mentions
- Men Lose Y Chromosomes as They Age. It May Be Harming Their HeartsJuly 14th, 2022
- The Multiple Causes and Treatments of Heart Failure: Focus on Genetic and Molecular Mechanisms and Non-Pharmacological InterventionsOctober 29th, 2020
- Frontiers of Acute Coronary and Aortic Syndromes: Outcomes, Novel Prognostic Markers, and Cardiogenic ShockAugust 21st, 2019
- Join now to see all
Professional Memberships
- Member